Chemo-Free Regimen Feasible in High-Risk Luminal Breast Cancer
Downstaging just as frequent with endocrine therapy plus CDK4/6 inhibitor
Related Articles
Does Ronny Jackson Have an Active Medical License?
The question arose after his memo on Trump’s treatment following an assassination attempt
Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults
Bone formation is impaired in both type 1 diabetes and type 2 diabetes (T2D), whereas sclerostin, an antagonist of bone formation, is increased in T2D…
Gynecology Queries Surged After Barbie Movie Release
But how did the ‘Barbie effect’ impact those searches?
Why Is Doctor Pay Decreasing and What Can We Do About It?
It’s time to take back control of our profession
Dementia Risk Drops With Shingrix Vaccine
Recombinant shingles vaccine tied to 164 additional days without dementia diagnosis
Long-Acting Cabotegravir Appears Safe in Pregnancy
Maternal, neonatal outcomes are similar to background rates, analysis finds
Opinion | Ridden With Shame as a ‘Gray Area’ Drinker
Like many doctors, I decided I had to get sober
New Meta-Analysis on Safety of JAK Inhibitors for Patients With Atopic Dermatitis
Among patients being treated with JAK inhibitors for atopic dermatitis (AD), the risk for some adverse events increased relative to those taking placebo, but the…
Where Kamala Harris Stands on Key Healthcare Issues
MedPage Today looks at the vice president’s views on everything from abortion to Medicare